National studies

FUNDED PROJECTS

Since 2020 the center has co-financed the projects focusing on documenting the positive effects of using ctDNA guided cancer treatment. Here you can read about the projects - be inspired or create new collaborations.

0
Numbers of funded projects

CURE - Clinical Utility of Circulating Tumor DNA in Gastro-Esophageal Cancer


Cecilie Riis Iden
MD, PhD-student
Department of Oncology
Rigshospitalet


Circulating Tumor DNA for early Detection of Recurrence and Risk-stratification in Melanoma


Magnús Pétur Bjarnason Obinah
MD, PhD Student
Department of Plastic Surgery
Herlev and Gentofte Hospital


Circulating Tumor-DNA for the Proper Allocation of Completion Resection in early Colorectal Cancer


Mads Falk Klein
MD, PhD, Associate Professor
Department of Surgery
Herlev and Gentofte Hospital


NOAC 9 - A Phase II Randomised Nordic Anal Cancer Group Study on Circulating Tumor DNA guided Follow-Up

Karen-Lise Garm Spindler
Dr. Med., PhD, Consultant, Professor
Department of Oncology
Aarhus University Hospital


CIRQUESARC - A National Prospective Observational Study of Circulating Tumor DNA and Quality of Life in Sarcomas

Joanna Vitfell-Rasmussen,
MD, Clinical Oncologist, PhD-student
Department of Oncology
Herlev University Hospital


The Diverticulitis Study - Circulating tumor DNA guided vs. opportunistic colonoscopy screening for CRC detection after acute colonic diverticulitis

Claus Lindbjerg Andersen
M.Sc., Ph.D., Professor
Department of Molecylar Medicine
Aarhus University Hospital


ISCOLIM - Improving Survival of Colo-rectal Liver Metastase by RFA-mediated Immuno-stimulation


Frank Viborg Mortensen
DMSc, Professor
Department of Surgery L
Aarhus University Hospital


Analyzing circulating tumor DNA as a marker for response to treatment in the NORDIC-SUN clinical trial


Iben Lyskjær Heimann
Associate Professor
Department of Molecular Medicine
Aarhus University Hospital


SUPE_R - Kan opfølgning efter behandling for lungekræft forbedres med analyse af cirkulerende tumor DNA?


Barbara Malene Fischer
Chief Physician, Professor
Clinical Physiology and Nuclear Medicine
Rigshospitalet


RESPONSE: Colorectal cancer survivors’ follow-up care – now digital and need-based. A national interventional effectiveness trial for stage I and II patients


Mai-Britt Worm Ørntoft
MD., PhD., Postdoctoral Researcher
Department of Molecular Medicine
Aarhus University Hospital


DETECT - Early detection of lung cancer by blood samples - A prospective national observational study



Sara Witting Christensen Wen
PhD-student
Department of Oncology
Sygehus Lillebælt, Vejle


Early Detection of Treatment Failure by Circulating Tumor DNA in Advanced non-small Cell Lung Cancer


Malene Støchkel Frank
MD, PhD
Department of Clinical Oncology
Zealand University Hospital
 


Close Monitoring of Treatment Response of Patients with Metastatic Non-Small Cell Lung Cancer using Liquid Biopsy with focus on ctDNA methylation and ctRNA PD-L1 status

Christina Søs Audur Andersen
Molecular Biologist, PhD-student
Department of Pathology
Zealand University Hospital

 
ctDNA analysis of rectal cancer treated in the watchful waiting setting

Edina Dizdarevic
PhD-student
Department of Oncology
Sygehus Lillebælt, Vejle


De novo cancer in liver transplant recipients (DETECT) – a ScandiaTransplant collaboration


Hans-Christian Pommergaard
Associate Professor
Department of Surgery and Transplantation
Rigshospitalet


TOMBOLA - Treatment Of Metastatic Bladder cancer at the time Of biochemical reLApse following radical cystectomy


Lars Dyrskjøt Andersen
PhD., Professor
Department of Molecular Medicine
Aarhus University Hospital and Aarhus University


PRELUCA - Circulating tumor DNA guided treatment-monitoring in advanced lung cancer - a randomized interventional study

Malene Støchkel Frank
PhD., Senior Registrar
Department of Clinical Oncology and Palliative Care
Zealand University Hospital, Næstved